News

In a small pilot study, presented at the recent 2016 ASCO Annual Meeting, researchers are evaluating whether wearable activity monitors can help clinicians to better assess patient well-being between office visits.

An analysis of over 28,000 patients younger than 65 with incurable cancers found that approximately three-fourths of them received aggressive care within the last 30 days of life and one-third died in the hospital.

On June 6, 2016, during the annual meeting of the American Society of Clinical Oncology (ASCO), Vice President Joe Biden unveiled the Genomic Data Commons (GDC) project.

Researchers in France have found that patients with lung cancer who used a web-based app to report and track their symptoms achieved impressive gains in survival compared with individuals who were followed using standard protocols.

Women who extended their adjuvant therapy with an aromatase inhibitor (AI) to 10 years after treatment for their early-stage HR-positive breast cancer reduced their risk of recurrence by more than a third and experienced no new toxicities or worsening of quality of life.

Researchers are hoping that a new nationwide effort aimed at helping patients to share their tumor samples and clinical information will lead to new discoveries and better treatments for metastatic breast cancer.

Women with a history of infertility, and have undergone hormonal fertility treatment have denser breast tissue, which may increase their risk of developing breast cancer, according to a study published in the journal Breast Cancer Research.

Despite the proven effectiveness of a targeted drug for HER2-positive breast cancer, older women, especially black women, are still receiving it at low rates, according to a study conducted by researchers at the University of North Carolina at Chapel Hill (UNC) Lineberger Comprehensive Cancer Center.

Oncology nurses are administering hazardous drugs every day. While some take precaution by using Personal Protective Equipment (PPE), others take a much riskier approach.

Researchers have discovered that shorter, more intensive radiation treatment for patients in the early stages of prostate cancer can be performed without compromising cancer control.

On May 25, 2016, the American Society of Clinical Oncology (ASCO) released evidence-based, resource-stratified global recommendations on the management and palliative care of women diagnosed with invasive cervical cancer.

Though there are few therapeutic options for patients with myelofibrosis, ruxolitinib (Jakafi) represents an important look towards the future, according to Maureen E. Thyne, a physician assistant in the Outpatient Leukemia Service at Weill Cornell Medical College.

Research suggests that 25% to 40% of individuals receiving chemotherapy experience persistent mild to moderate cognitive changes, and a study of breast cancer survivors suggests that a new type of psychotherapy delivered by videoconference may help reduce these effects, often referred to as “chemobrain.”

Resources and information about possible loss of fertility after cancer treatment and preservation measures to prevent infertility are sorely lacking for young women, according to a new study.

Researchers conducted interviews of patients’ decision-makers to determine how well their understanding of a patient’s prognosis aligned with the physician’s prognostic estimate. The patients were receiving care in the intensive care unit and were identified by physicians as having a high risk of death.

Older patients with cancer experience greater declines in physical functioning, according to a recent study published in the journal Cancer. Further, these patients also were at an increased risk of depression.

Intercom announcements, bright lights, nurses bustling in and out of rooms—faced with these disturbances in a hospital, any patient would likely get a terrible night’s sleep.

Adults with HIV and cancer are less likely to receive cancer treatment than patients who are solely suffering from cancer, according to a recent study published in the journal Cancer.

The 3-year survival rate of patients with advanced melanoma treated with pembrolizumab (Keytruda) has reached 40%, with many responders in remission even after stopping treatment.

Early palliative care integrated with oncology care benefits not only patients with cancer but also family caregivers.

The FDA granted the PD-L1 inhibitor atezolizumab (Tecentriq) an accelerated approval as a treatment for patients with locally advanced or metastatic urothelial carcinoma.

A collaborative patient reported outcome (PRO)-based care approach resulted in better outpatient symptom management and a decrease in end-of-life hospitalizations and costs for late-stage cancer patients.

The FDA granted nivolumab (Opdivo) accelerated approval for the treatment of patients with classical Hodgkin lymphoma (cHL) that has relapsed or progressed after autologous hematopoietic stem cell transplantation (HSCT) and posttransplantation brentuximab vedotin (Adcetris).